Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 15, 2014 - Issue 10
Submit an article Journal homepage
223
Views
6
CrossRef citations to date
0
Altmetric
Drug Evaluations

Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients

Francesco LocatelliAlessandro Manzoni Hospital, Department of Nephrology Dialysis and Renal Transplantation, Via Dell’Eremo 9, Lecco, 23900, Italy+39 0341 489850; +39 0341 489860; [email protected]
, MD FRCP,
Nada DimkovicUniversity of Belgrade, Institute for Medical Research, Medical Faculty, 2 Pasterova Street, Belgrade, Serbia
, MD &
Goce SpasovskiUniversity of Skopje, Department of Nephrology, Medical Faculty, Vodnjanska 17 1000 Skopje, Macedonia
, MD
Pages 1475-1488 | Published online: 10 Jun 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

J. Bover, P. Ureña-Torres, M. J. Lloret, C. Ruiz-García, I. DaSilva, M. M. Diaz-Encarnacion, C. Mercado, S. Mateu, E. Fernández & J. Ballarin. (2016) Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Expert Opinion on Pharmacotherapy 17:9, pages 1247-1258.
Read now
Pavlos Malindretos & Mario Cozzolino. (2016) Phosphate binders, past – present – future. A critical appraisal.. Expert Opinion on Pharmacotherapy 17:3, pages 297-300.
Read now
Goce Spasovski. (2015) Advances in pharmacotherapy for hyperphosphatemia in renal disease. Expert Opinion on Pharmacotherapy 16:17, pages 2589-2599.
Read now

Articles from other publishers (3)

Wendy L. St. Peter, Lori D. Wazny, Eric Weinhandl, Katie E. Cardone & Joanna Q. Hudson. (2017) A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?. Drugs 77:11, pages 1155-1186.
Crossref
Jürgen Floege. (2016) Phosphate binders in chronic kidney disease: a systematic review of recent data. Journal of Nephrology 29:3, pages 329-340.
Crossref
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov. (2015) Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease. Clinical Investigation 5:1, pages 9-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.